Barclays’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$463K Sell
14,594
-6,108
-30% -$214K ﹤0.01% 3516
2026
Q2
$716K Buy
20,702
+16,334
+374% +$494K ﹤0.01% 2994
2026
Q1
$123K Buy
4,368
+1,593
+57% +$42.5K ﹤0.01% 3936
2025
Q4
$77K Buy
+2,775
New +$66.8K ﹤0.01% 4649
2025
Q3
– Sell
-2,796
Closed -$49.2K – 5674
2025
Q2
$49.2K Sell
2,796
-65
-2% -$1.05K ﹤0.01% 4711
2025
Q1
$44.9K Sell
2,861
-3
-0.1% -$51 ﹤0.01% 4639
2024
Q4
$54.9K Sell
2,864
-2,836
-50% -$58.4K ﹤0.01% 4744
2024
Q3
$106K Buy
+5,700
New +$104K ﹤0.01% 4560

Other funds holding PHVS

Barclays's PHVS Position: Q3 2026 in Review

Barclays reduced its Pharvaris (PHVS) stake by 30% in Q3 2026, selling an estimated $214K and leaving 14,594 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #3516.

Barclays first reported a position in PHVS in Q3 2024 and has held it in 8 quarters since. The position peaked at $716K in Q2 2026. 31 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.

  • Barclays held 14,594 shares of Pharvaris worth $463K as of Q3 2026.
  • Barclays sold 6,108 Pharvaris shares in Q3 2026, an estimated $214K.
  • Pharvaris made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3516 holding.
  • Barclays first reported a position in Pharvaris in Q3 2024 and has held it in 8 quarters since.
  • Barclays's Pharvaris position peaked at $716K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.